Search by Drug Name or NDC
NDC 51754-1210-03 Bloxiverz 0.5 mg/mL Details
Bloxiverz 0.5 mg/mL
Bloxiverz is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Exela Pharma Sciences, LLC. The primary component is NEOSTIGMINE METHYLSULFATE.
Product Information
| NDC | 51754-1210 |
|---|---|
| Product ID | 51754-1210_f203ef67-80a5-1ef2-e053-2995a90a961c |
| Associated GPIs | 76000040202017 |
| GCN Sequence Number | 071070 |
| GCN Sequence Number Description | neostigmine methylsulfate VIAL 0.5 MG/ML INTRAVEN |
| HIC3 | J1B |
| HIC3 Description | CHOLINESTERASE INHIBITORS |
| GCN | 34758 |
| HICL Sequence Number | 001988 |
| HICL Sequence Number Description | NEOSTIGMINE METHYLSULFATE |
| Brand/Generic | Brand |
| Proprietary Name | Bloxiverz |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Neostigmine Methylsulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 0.5 |
| Active Ingredient Units | mg/mL |
| Substance Name | NEOSTIGMINE METHYLSULFATE |
| Labeler Name | Exela Pharma Sciences, LLC |
| Pharmaceutical Class | Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA204078 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 51754-1210-03 (51754121003)
| NDC Package Code | 51754-1210-3 |
|---|---|
| Billing NDC | 51754121003 |
| Package | 10 CARTON in 1 PACKAGE (51754-1210-3) / 1 VIAL, MULTI-DOSE in 1 CARTON (51754-1210-1) / 10 mL in 1 VIAL, MULTI-DOSE |
| Marketing Start Date | 2013-07-24 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |